Ranibizumab-leyk
Generic Name: ranibizumab-leyk
Manufactured by FORMYCON AG. Dosage form: INJECTION. Active ingredients: RANIBIZUMAB-LEYK (10MG/ML). Application: BLA761473.
Overview
Manufactured by FORMYCON AG. Dosage form: INJECTION. Active ingredients: RANIBIZUMAB-LEYK (10MG/ML). Application: BLA761473.
Dosage
Available as injection.
Related Medications
Bismuthum Subnitricum
bismuthum subnitricum
Penicillin V
penicillin v
Manufactured by LILLY. Dosage form: FOR SUSPENSION. Route: ORAL. Active ingredients: PENICILLIN V (125MG/0.6ML). Application: ANDA060002.
Candesartan Cilexetil
candesartan cilexetil
11 DESCRIPTION Candesartan cilexetil, a prodrug, is hydrolyzed to candesartan during absorption from the gastrointestinal tract. Candesartan is a selective AT 1 subtype angiotensin II receptor antagonist. Candesartan cilexetil, a nonpeptide, is chemically described as (±)-1-Hydroxyethyl 2-ethoxy-1-[ p-(o -1 H -tetrazol-5-ylphenyl)benzyl]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.